Harvard Bioscience Appoints Jennifer Cote As Chief Financial Officer
Portfolio Pulse from Benzinga Newsdesk
Harvard Bioscience has appointed Jennifer Cote as its new Chief Financial Officer. Cote brings extensive experience in finance and operations, which is expected to benefit the company.
June 20, 2023 | 12:02 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Jennifer Cote's appointment as CFO of Harvard Bioscience is expected to bring valuable finance and operations experience to the company.
Jennifer Cote's appointment as CFO is expected to have a positive impact on Harvard Bioscience's stock price in the short term. Her extensive experience in finance and operations will likely contribute to the company's financial stability and growth.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100